RecruitingPhase 3NCT06852222A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)Sponsor: Janssen Research & Development, LLCCanton, OH · Centerville, OH · Cincinnati, OH · +56 more sites
RecruitingPhase not listedNCT02012699Integrated Cancer Repository for Cancer ResearchSponsor: University of NebraskaAlliance, OH · Canton, OH · +40 more sites
RecruitingPhase 1 / Phase 2NCT04329728The OPAL Study: AVM0703 for Treatment of Lymphoid MalignanciesSponsor: AVM Biotechnology IncCanton, OH · +10 more sites